GALECTIN THERAPEUTICS INC - COMMON STOCK (GALT)

CUSIP: 363225202

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
+2,308,289
Put/Call ratio
5.6%
SEC-reported price per share
$2.79
Number of holders
99
Value change
+$5,713,069
Number of buys
47
Open additional details 1 more signal available
Number of sells
37
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
110,899,890

Security key

363225202

Report period

Q1 2026

Institutions

99

Top holders

10

Ownership snapshot

Top reported holders of GALT - GALECTIN THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
10X Fund, L.P.
Disclosed value leader
10X Fund, L.P.
Comparable rows
0/15
Latest evidence
16 Jan 2026
3/4/5 13F Highest disclosed value: $37,392,283 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

10X Fund, L.P. has the largest disclosed position value at $37.39M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 10X Fund, L.P.'s linked filing trail.
Disclosed position value Top 5
10X Fund, L.P. $37.39M
James C. Czirr $1.16M
VANGUARD GROUP INC $9.52M
OSAIC HOLDINGS, INC. $4.54M
BlackRock, Inc. $3.31M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
10X Fund, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$37,392,283
5,614,457 shares
-$1,581,991 02 Dec 2025
James C. Czirr
3/4/5
10%+ Owner
—
denominator unverified
$1,160,550
1,045,541 shares
— 03 Feb 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$9,521,608
2,288,848 shares
— 31 Dec 2025
OSAIC HOLDINGS, INC.
13F
Company
13F
—
denominator unverified
$4,536,850
1,090,590 shares
— 31 Dec 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$3,313,681
796,558 shares
— 31 Dec 2025
Joel Lewis
3/4/5
President and CEO, Director
—
mixed-class rows
$3,213,845
969,260 shares
mixed-class rows
-$620,536 16 Jan 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
99
Shares
13,940,867
Rows available
99
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
99
Q1 2026 holders
99
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .